Lumbacurve International Limited

LumbaCurve International specializes in innovative therapeutic devices designed to alleviate lower back pain, employing patented technology to provide effective relief for users across various sectors. LumbaCurve International is focused on the design and manufacture of therapeutic solutions targeting lower back pain, particularly in the lumbar regions (L4, L5, S1). Founded and led by CEO David Pegg, the company is headquartered in Accrington, UK. In January 2013, LumbaCurve raised GBP 130,000 in funding from North West Business Finance and SPARK Ventures, marking a pivotal moment in its growth.

This funding round was part of the company's strategy to enhance its market presence with its flagship product, the LumbaCurve device. LumbaCurve International develops a patented therapeutic device, the LumbaCurve, designed specifically to relieve lower back pain through passive gravity-assisted traction. This device targets occupational and recreational users suffering from lumbar discomfort. It has been clinically validated against UK NHS treatment guidelines and is available primarily in the UK with worldwide shipping options.

LumbaCurve's revenue model is based on direct-to-consumer sales of the LumbaCurve device, priced at GBP 49. 95, which includes free UK delivery. The company facilitates transactions via its online platform, ensuring customer satisfaction with a 30-day money-back guarantee. Future plans may include partnerships with health professionals and wellness centers to diversify revenue streams.

Following the recent funding round completed in January 2013, LumbaCurve plans to utilize the raised GBP 130,000 to support the development of new products and to expand its market reach. The company aims to introduce additional therapeutic devices targeting broader demographic groups by the end of 2024. Furthermore, LumbaCurve is exploring opportunities to enter international markets, enhancing its distribution capabilities to cater to users beyond the UK.